A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal Hemorrhoids
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
"Internal hemorrhoid" affects the quality of life due to hemorrhage and prolapse as a common
and frequently-occurring disease. Endoscopic sclerosing agent injection has replaced
traditional surgery and become the most commonly used treatment method in developed
countries. At present, how to reduce the side effects of sclerosing agent and accurately
determine the injection site and depth has become a difficult clinical problem. The research
group creatively put forward the theory of foam sclerosing agent to treat internal
hemorrhoids in the early stage. With the aid of transparent cap, the visibility of surgical
field of vision can be improved. The mini probe ultrasound (MPS) is proposed to effectively
evaluate the submucosal in
Phase:
Phase 4
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators:
Anhui Provincial Hospital Changzhi People's Hospital Ganzhou Fifth pepole's Hospital Jiangsu Provincial Second Chinese Medicine Hospital Luoyang Central Hospital Nanjing PLA General Hospital Shandong Maternal and Chidl Care Service Center Shanghai Construction Group Hospital Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University The First Affiliated Hospital of Zhengzhou University The First Hospital of Anhui Medical University Tongren Hospital,Shanghai Jiao Tong University School of Medicine West China Forth University Hospital，Sichuan University